Drug maker hires former Sen. Breaux to fight federal debarment threat


At the time, the company put out a statement saying it would resist. 

"It would be completely unwarranted to exclude a senior executive against whom there has never been any allegation of wrongdoing whatsoever," the statement said. "We are hopeful that HHS-OIG [Office of Inspector General] will decide that the facts and circumstances as to Mr. Solomon do not warrant an exercise of its exclusion authority."

The lobbying registration from Breaux's company, Breaux Lott Leadership Group, says simply that the firm has been hired to lobby on "(i)ssues with respect to debarment under HHS regulations."

Neither Forest nor the lobbying firm immediately responded to a request for comment.

Clarification: This post was updated Friday to better reflect the fact that HHS' debarment threat targets Howard Solomon, not Forest Labs.